Oslo Science City has published a feature on the Intervention Centre (IVS) at Oslo University Hospital.

Why do global medtech companies choose Oslo as a test arena? 
Established in 1996, the Intervention Centre marks 30 years this year. It combines high-tech operating rooms, research infrastructure and clinical activity under one roof — a "small hospital" within the hospital. Around half of the staff have a clinical background; the other half come from other fields such as technology and engineering, and work inside the clinical activity rather than in support functions.
Partners such as Siemens Healthineers, GE HealthCare and Medtronic collaborate with IVS on equal terms: industry contributes technology and development capacity, while IVS contributes clinical experience, patient insight and research expertise. Head of department Mona-Elisabeth Rootwelt-Revheim describes the result as "a complete and professionalised research-driven innovation platform".
The feature also follows innovation from idea to documented practice — from pilot studies through randomised trials to registry research, measuring quality of life and health economics alongside clinical outcomes. As Professor Emeritus Bjørn Edwin puts it: "If you don't publish the results, it has never really been done.

Read the article (in Norwegian): https://www.oslosciencecity.no/aktuelt/nyheter/global-testarena-oslo